Picard Medical, Inc. (PMI) stock
PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3076% above fair value
$6.91−0.33 (-4.56%)
Close on Nov 17, 2026Market cap $16.16MP/E –Yield –
Picard Medical gross margin
Gross margin is gross profit as a percentage of revenue.
Picard Medical's gross margin for the twelve months ending Sep 30, 2026 was 26.2%. For fiscal 2025 it was -4.1%, against -2.6% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -4.1% | −1.6 |
| FY2024 | Dec 31, 2024 | -2.6% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 43.8% | +54.7 |
| Q2 FY2026 | Jun 30, 2026 | 20.9% | +26.8 |
| Q1 FY2026 | Mar 31, 2026 | 23.9% | +81.7 |
| Q4 FY2025 | Dec 31, 2025 | 40.7% | +24.5 |
| Q3 FY2025 | Sep 30, 2025 | -11.0% | +65.4 |
| Q2 FY2025 | Jun 30, 2025 | -6.0% | +49.1 |
| Q1 FY2025 | Mar 31, 2025 | -57.7% | – |
| Q4 FY2024 | Dec 31, 2024 | 16.3% | – |
| Q3 FY2024 | Sep 30, 2024 | -76.4% | – |
| Q2 FY2024 | Jun 30, 2024 | -55.0% | – |
See a number that looks wrong?